The Canadian Neuromuscular Disease Registry and Amylyx Pharmaceuticals Partner on Real-World Evidence Generation for a Novel Investigational Therapy in ALS with the Goal of Advancing Health Outcomes for Canadians Living with ALS

February 03, 2022 08:00 AM Eastern Standard Time CALGARY, Alberta & TORONTO–(BUSINESS WIRE)–The Canadian Neuromuscular Disease Registry (CNDR), an independent, academic registry based out of the University of Calgary, and...

EVERSANA and Integra Connect Form Strategic Partnership to Advance Next Generation Oncology Commercialization Services Propelled by Real-World Evidence & Technology Platforms

CHICAGO, Feb. 3, 2022 /PRNewswire/ — EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, today announced a strategic partnership with Integra Connect, LLC, designed to support life sciences...